Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017 Gene-Editing Leader Horizon Discovery to Go on Global Hiring Spree April 30, 2017 Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub October 8, 2017
Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017
